Most recently, his group clarified the involvement of aberrant renal b adrenergic receptor-WNK4 pathway in salt- induced hypertension (Nat Med 2011). A renowned expert in his field, Professor Fujita has been actively contributing to professional associations and scien- tific publications and his contribution to the study of hypertension and kidney diseases has been widely recognized. In 2009, Professor Fujita was awarded Arthur Corcoran Lecture Award by the Council for High Blood Pressure Research, American Heart Association (AHA). Over the past 30 years, Professor Fujita has published over 500 scientific articles and has been a member of the Committee of the High Blood Pressure Council, AHA. Professor Fujita is currently serving as a Consulting Editor for Hypertension and an Editorial Board member for Diabetes. He was Past President of the Japanese Society of Hypertension (2003 2005), the Japanese Society of Internal Medicine (2004 2006), the Japanese Society of Endocrinology (2006 2007), and the Japanese Society of Nephrology (2009 2010). He was also Vice-President, International Society of Hypertension (2008 2010). Speaker: Astellas; Boehringer Ingelheim; Daiichi Sankyo; Merck; Mitsubishi Tanabe; Mochida; Novartis; Pfizer; Takeda Grant/Research Support: Astellas; Boehringer Ingelheim; Daiichi Sankyo; Merck; Mitsubishi Tanabe; Mochida; Novartis; Pfizer; Takeda Susan L Furth, MD, PhD, is Chief, Divison of Pediatric Nephrology at Children s Hospital of Philadelphia and Professor, Department of Pediatrics and Epidemiology, Perelman School of Medicine at University of Pennsylvania School of Medicine, where she is also currently a Senior Scholar and faculty member at the institution s Center for Clinical Epidemiology and Biostatistics. Dr Furth received her medical degree from University of Pennsylvania and doctorate degree from Johns Hopkins University School of Hygiene and Public Health. She maintains a longstanding interest in the studies of children and adolescents with kidney disease, particularly their risk factors and consequences, including pediatric hypertension. 